Public Employees Retirement Association of Colorado’s Celldex Therapeutics CLDX Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$247K	Hold	7,787	–	–	﹤0.01%	1353
2025 Q4	$211K	Hold	7,787	–	–	﹤0.01%	1452
2025 Q3	$201K	Hold	7,787	–	–	﹤0.01%	1467
2025 Q2	$158K	Hold	7,787	–	–	﹤0.01%	1534
2025 Q1	$141K	Hold	7,787	–	–	﹤0.01%	1579
2024 Q4	$197K	Hold	7,787	–	–	﹤0.01%	1507
2024 Q3	$265K	Hold	7,787	–	–	﹤0.01%	1370
2024 Q2	$288K	Hold	7,787	–	–	﹤0.01%	1266
2024 Q1	$327K	Buy	+7,787	New	+$320K	﹤0.01%	1230
2018 Q2	–	Sell	-1,646	Closed	-$58K	–	1909
2018 Q1	$58K	Hold	1,646	–	–	﹤0.01%	1820
2017 Q4	$70K	Hold	1,646	–	–	﹤0.01%	1820
2017 Q3	$71K	Hold	1,646	–	–	﹤0.01%	1740
2017 Q2	$61K	Hold	1,646	–	–	﹤0.01%	1768
2017 Q1	$89K	Hold	1,646	–	–	﹤0.01%	1725
2016 Q4	$87K	Hold	1,646	–	–	﹤0.01%	1743
2016 Q3	$100K	Hold	1,646	–	–	﹤0.01%	1727
2016 Q2	$108K	Hold	1,646	–	–	﹤0.01%	1728
2016 Q1	$93K	Hold	1,646	–	–	﹤0.01%	1767
2015 Q4	$387K	Hold	1,646	–	–	﹤0.01%	1237
2015 Q3	$260K	Hold	1,646	–	–	﹤0.01%	1450
2015 Q2	$623K	Sell	1,646 -118	-7%	-$46.9K	0.01%	1123
2015 Q1	$737K	Sell	1,764 -154	-8%	-$55.1K	0.01%	1065
2014 Q4	$525K	Hold	1,918	–	–	﹤0.01%	1205
2014 Q3	$373K	Hold	1,918	–	–	﹤0.01%	1340
2014 Q2	$470K	Hold	1,918	–	–	﹤0.01%	1275
2014 Q1	$508K	Hold	1,918	–	–	﹤0.01%	1228
2013 Q4	$697K	Hold	1,918	–	–	0.01%	1103
2013 Q3	$1.02M	Sell	1,918 -618	-24%	-$212K	0.01%	915
2013 Q2	$594K	Buy	+2,536	New	+$499K	0.01%	1126

Other funds holding CLDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Public Employees Retirement Association of Colorado's CLDX Position: Q1 2026 in Review

Public Employees Retirement Association of Colorado held its Celldex Therapeutics (CLDX) position steady in Q1 2026 at 7,787 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

Public Employees Retirement Association of Colorado first reported a position in CLDX in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.02M in Q3 2013. 228 funds tracked by Wall St. Rank hold CLDX as of Q1 2026.

Public Employees Retirement Association of Colorado held 7,787 shares of Celldex Therapeutics worth $247K as of Q1 2026.
Public Employees Retirement Association of Colorado left its Celldex Therapeutics share count unchanged in Q1 2026.
Celldex Therapeutics made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q1 2026, its #1353 holding.
Public Employees Retirement Association of Colorado first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 29 quarters since.
Public Employees Retirement Association of Colorado's Celldex Therapeutics position peaked at $1.02M in Q3 2013.
228 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q1 2026, filed 14 May 2026.